Kilpest India-led arm bags order for its CE-IVD TRUPCR Panel Kit

18 Aug 2022 , 01:56 PM

Kilpest India Limited announced that its subsidiary company M/s. 3B BlackBio Biotech India Limited has got an export order valued at Rs2 crore.
The order received is for its recently launched CE-IVD TRUPCR UTI ID Panel Kit and TRUPCR UTI AST Panel Kit.

This RT-PCR-based multiplex panel detects and differentiates 14 pathogens that cause urinary tract infections (UTI) as well as 14 antimicrobial resistance (AMR) genes encoding resistance to 5 classes of antibiotics in a single run directly from native urine samples within 5 hours.

This assay will not only aid in the early detection of patient infections but will also assist clinicians in selecting the most effective antibiotic class for treatment, thereby reducing the spread and rise of antibiotic resistance.

Due to confidentiality reasons, the customer details and terms of the transactions have not been disclosed by the company. This export order will pave way for bigger opportunities for the company as it bestows the trust of its customers.

TRUPCR products are also available through TRUPCR Europe Ltd, a European subsidiary of 3B BlackBio Biotech India based in Manchester, UK. For European customers, the European subsidiary provides direct technical support, sales, and logistics.

At around 1.59 PM, Kilpest India was trading at Rs379 down by 0.3% from its previous closing of Rs380.15 on the BSE. The scrip touched intraday high and low of Rs386.90 and Rs368.10 respectively.